<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03202849</url>
  </required_header>
  <id_info>
    <org_study_id>2016-9480</org_study_id>
    <nct_id>NCT03202849</nct_id>
  </id_info>
  <brief_title>A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation</brief_title>
  <official_title>A Randomized Double Blinded Trial of Vitamin D Supplementation With or Without Vitamin A Supplementation in Allogeneic Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that supplementation with vitamins A and D will reduce the
      incidence of acute gastrointestinal graft versus host disease (GI GVHD) compared with
      supplementation with vitamin D alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators' preliminary data suggest that low levels of vitamin A directly impact risk
      of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) and they
      believe supplemental vitamin A at the time of hematopoietic stem cell transplantation (HSCT)
      can reduce the risk of MBI-LCBI and gastrointestinal graft versus host disease (GI GVHD). In
      addition, the investigators' preliminary data suggest that a significant number of patients
      requiring HSCT have vitamin D deficiency even prior to transplantation, and that persistent
      and newly developed deficiency post-HSCT resulted in worse outcomes.

      This study is a comparison of vitamin D supplementation comparing a single large dose of
      vitamin D &quot;stoss therapy&quot; with a placebo in the standard care arm with supplementation with
      single large doses of both vitamins D and A in the experimental arm. Participants will be
      randomly assigned to either the standard care arm or the experimental arm.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2018</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GI GVHD</measure>
    <time_frame>100 days after transplant</time_frame>
    <description>Incidence of acute GI GVHD at day +100 after transplant. GVHD will be graded by the treating physician as per the modified Glucksberg criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MBI-LCBI</measure>
    <time_frame>100 days after transplant</time_frame>
    <description>Incidence of MBI-LCBI at day +100 after transplant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Related Mortality</measure>
    <time_frame>100 days after transplant</time_frame>
    <description>Treatment related mortality at day +100 after transplant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>1 year after transplant</time_frame>
    <description>Overall survival at 1 year after transplant.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hematopoietic Stem Cell Transplant</condition>
  <arm_group>
    <arm_group_label>Vitamin D and A Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a single dose of vitamin D and a single dose of vitamin A prior to HSCT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D Supplementation with Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive a single dose of vitamin D and a single dose of placebo prior to HSCT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D and A</intervention_name>
    <description>A single dose of Vitamin A and Vitamin D will be given.</description>
    <arm_group_label>Vitamin D and A Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D and Placebo</intervention_name>
    <description>A single dose of Vitamin D plus a placebo will be given.</description>
    <arm_group_label>Vitamin D Supplementation with Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for allogeneic stem cell transplant

          -  Vitamin D level &lt; 50 ng/ml

          -  Vitamin A level &lt; 75th centile for age

          -  Able to tolerate enteral vitamin dose administration

        Exclusion Criteria:

          -  History of pathologic fractures

          -  Known history of nephrocalcinosis or nephrolithiasis

          -  Current granulomatous disease

          -  ALT &gt; 10X ULN for age prior to administration of vitamin A

          -  Ongoing raised intracranial pressure

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stella Davies, MBBS, PhD, MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melanie Jordan</last_name>
    <phone>(513) 636-4379</phone>
    <email>Melanie.Jordan@cchmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Jordan</last_name>
      <phone>513-636-4379</phone>
      <email>Melanie.Jordan@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Stella Davies, MBBS, PhD, MRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2017</study_first_submitted>
  <study_first_submitted_qc>June 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hematopoietic stem cell transplant</keyword>
  <keyword>vitamin a</keyword>
  <keyword>vitamin d</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

